pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Immunology · news · pharmadog
← back to Immunology
News · Immunology
692
stories
7d
AbbVie wins FDA approval for Parkinson’s drug from $8.7B Cerevel takeover
biospace
7d
Tolerance continues thymus-focused deals with $560M pact for Tanabe's clinical-stage IL-33 drug
fiercebiotech
7d
Opinion: AI is eroding the barriers that kept biological weapons rare
stat
7d
STAT+: Once described as obesity medicines for ‘patients,’ GLP-1s are increasingly lifestyle drugs for ‘customers’
stat
7d
Regenerative medicine needs more than stem cells
biospace
7d
6 immunology targets to sustain a mammoth I&I market
biospace
10d
STAT+: Lilly wins approval for once-weekly insulin shot
stat
10d
Nektar prevails in legal battle with Lilly over broken rezpeg partnership
biospace
10d
Adicet Bio CAR-T sparks lupus remissions in early trial as ‘new era’ of autoimmune treatment approaches
fiercebiotech
10d
ADARx raises $446M in biotech’s third largest IPO of 2026, City files to go public
biospace
10d
STAT+: Pharmalittle: We’re reading about a reticent FDA commish nominee, a Novo deal, and more
stat
10d
J&J, Legend tout long-term survival benefits for Carvykti in multiple myeloma
biospace
10d
Novo pursues long-acting obesity drugs; Acadia slumps on Alzheimer’s data
biopharma dive
10d
Genentech makes $1.5B+ deal with AI heavyweight Earendil for cancer bispecifics
biospace
10d
Opinion: RFK Jr.’s use of the National Center for Health Statistics will add confusion to measles deaths count
stat
10d
Roche's Genentech inks $1.5B bispecific pact with fast-rising Earendil
fiercebiotech
10d
ADARx scores upsized $446M IPO, while fellow RNA biotech City maps out Nasdaq plans
fiercebiotech
10d
RNAi drug specialist ADARx raises $446M IPO
biopharma dive
10d
STAT+: FDA commissioner nominee Heidi Overton keeps opinions to herself in Senate hearing
stat
10d
The FDA’s Overton era, and dispatches from Shanghai
stat
11d
Lilly’s latest China drug deal; Immunovant’s setback in lupus
biopharma dive
11d
STAT+: Kyverna’s cell therapy shows lasting autoimmune benefit
stat
11d
Kyverna steps closer to FDA-first CAR T for an autoimmune condition with durability data
biospace
11d
Lilly sets aside up to $3.25B to tackle critical unmet need targets with InnoCare
biospace
11d
STAT+: Why Gilead can’t stop talking about its ambitions in immunology
stat
11d
Kyverna says long-term data bolster FDA submission for rare autoimmune CAR-T
endpoints
11d
Lilly puts up $100M, plus billions on the backend, to form 5-target deal with China's InnoCare
fiercebiotech
11d
Berlin Seeds Recalls Alfalfa Sprouting Seed Because of Possible Health Risk
fda recalls
11d
Enveda, an AI drugmaker, banks $311M in venture funding
biopharma dive
12d
Roche, Ionis RNA drug scores in kidney disease study
biopharma dive
← prev
page 3 of 24
next →
